Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer

Colorectal Disease

Volumn 15, Issue 3, 2013, Pages 323-328

  Mallappa, S ^a   Sinha, A ^a   Gupta, S ^a   Chadwick, S J D ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Elective curative resection; Neutrophil to lymphocyte ratio; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURGERY; COLON CANCER; COLORECTAL SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE ENDOSCOPY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NEUTROPHIL TO LYMPHOCYTE RATIO; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECTUM CANCER; RECURRENT CANCER; SCORING SYSTEM; STATISTICAL CONCEPTS;

ADULT; AGED; AGED, 80 AND OVER; COLECTOMY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INCIDENCE; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; PREOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84874371112     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12008     Document Type: Article

References (46)

1. Cancerstats, http://www.cancerresearchuk.org (accessed 2010).
2. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?Lancet 2001; 357: 539-45.
3. Garcea G, Ladwa N, Neal CP, Metcalfe MS, Dennison AR, Berry DP. Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. World J Surg 2011; 35: 868-72.
4. Vakilla J, Lotze MT. Inflammation and necrosis promote tumor growth. Nat Rev Immunol 2004; 4: 641-8.
5. Mantovani A, Romera P, Palucka AK et al. Tumor immunity: effector response to tumor and role of the microenvironment. Lancet 2008; 371: 771-83.
6. Roxburgh CSD, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010; 6: 149-63.
7. McMillan DC, Crozier JE, Canna K et al. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 2007; 22: 81-6.
8. Roxburgh CSD, Salmond JM, Horgan PG et al. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 2009; 249: 788-93.
9. Leitch E, Chakrabarti M, Crozier J et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer 2007; 97: 1266-70.
10. McMillan D. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009; 12: 223-6.
11. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-4.
12. Canna K, McArdle PA, McMillan DC et al. The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 2005; 92: 651-4.
13. Miki C, Konishi N, Ojima E et al. C-reactive protein as a prognostic variable that reflects uncontrolled up-regulation of the IL-1-IL-6 network system in colorectal carcinoma. Dig Dis Sci 2004; 49: 970-6.
14. Kandemir EG, Mayadagli A, Karagoz B et al. Prognostic significance of thrombocytosis in node-negative colon cancer. J Int Med Res 2005; 33: 228-35.
15. Ishizuka M, Nagata H, Takagi K et al. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 2007; 246: 1047-51.
16. Koike Y, Miki C, Okugawa Y et al. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol 2008; 98: 540-4.
17. Roxburgh CSD, Crozier JE, Maxwell F et al. Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer. Br J Cancer 2009; 100: 701-6.
18. Roxburgh CSD, Wallace AM, Guthrie GK et al. Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative surgery for colon cancer. Colorectal Dis 2010; 12: 987-94.
19. Kim US, Papatestas AE, Aufseses AH Jr. Prognostic significance of peripheral lymphocyte counts and carcinoembryonic antigens in colorectal carcinoma. J Surg Oncol 1976; 8: 257-62.
20. Thynne GS, Moertal CG, Silvers A. Preoperative lymphocyte counts in peripheral blood in patients with colorectal neoplasms: a correlation with tumor type, Dukes' classification, site of primary tumor, and five-year survival rate in 1000 patients. Dis Colon Rectum 1979; 22: 221-2.
21. Sasaki A, Kai S, Endo Y et al. Prognostic value of preoperative peripheral blood monocyte count in patients with colorectal liver metastasis after liver resection. J Gastrointest Surg 2007; 11: 596-602.
22. Monreal M, Fernandez-Llamazares J, Pinol M et al. Platelet count and survival in patients with colorectal cancer - a preliminary study. Thromb Haemost 1998; 79: 916-8.
23. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006; 83: 735-43.
24. Fearon KC, Voss AC, Hustead DS, Cancer Cachexia Study Group. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006; 83: 1345-50.
25. Halazun KJ, Aldoori A, Malik HZ et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008; 34: 55-60.
26. Yamanaka T, Matsumoto S, Teramukai S et al. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007; 73: 215-20.
27. Sarraf KM, Belcher E, Raevsky E et al. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg 2009; 137: 425-8.
28. Cho H, Hur HW, Kim SW et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother 2009; 58: 15-23.
29. Gomez D, Morris-Stiff G, Toogood GJ et al. Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 2008; 97: 513-8.
30. Gomez D, Farid S, Malik HZ et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 2008; 32: 1757-62.
31. Halazun KJ, Hardy MA, Rana AA et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 2009; 250: 141-51.
32. An X, Ding PR, Li YH et al. Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers 2010; 15: 516-22.
33. Jass JR, Love SB, Northover JM. A new prognostic classification of rectal cancer. Lancet 1987; 1: 1303-6.
34. Kao SCH, Pavlakis N, Harvie R et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res 2010; 16: 5805-13.
35. Tanigawa N, Amaya H, Matsumara M, Shimomatsuya T. Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 1997; 15: 826-32.
36. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis 2003; 6: 283-7.
37. Sharaiha RZ, Halazun KJ, Mirza F et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol 2011; 18: 3362-9.
38. Fondevila C, Metges JP, Fuster J et al. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer 2004; 90: 206-15.
39. Hung HY, Chen JS, Yeh CY et al. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy. Int J Colorectal Dis 2011; 26: 1059-65.
40. Ownby HE, Roi LD, Isenberg RR, Brennan MJ. Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer 1983; 52: 126-30.
41. Ferradini L, Miescher S, Stoeck M et al. Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma. Int J Cancer 1991; 47: 362-70.
42. Hang ZB, Wei YQ, Wang YP, Xu NR. Direct ultrastructural evidence of lymphocyte-mediated cancer cell lysis in the microenvironment of Chinese nasopharyngeal carcinoma. Hum Pathol 1991; 22: 320-5.
43. Kojya S, Itokazu T, Noda Y et al. Site-specific localization of Epstein-Barr virus in pharyngeal carcinomas. Jpn J Cancer Res 1998; 89: 510-5.
44. Kwon HC, Kim SH, Oh SY et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers 2012; 17: 216-22.
45. Malik HZ, Prasad KR, Halazun KJ et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 2007; 246: 806-14.
46. Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 2009; 16: 614-22.